Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
634studies shown
Showing 289-300 of 634
Drug study icon
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed in the United States, in France, in Canada, .... It focuses on depression.

In Canada
DepressionOtherFrom 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT05550532

Aticaprant 10 Milligrams (mg) for Depression

This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.

In Canada
DepressionOtherFrom 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Other study type icon
CompletedNCT05328297

JNJ-55308942 for depression in bipolarity

This study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.

In Canada
Bipolarity, DepressionOtherFrom 18 Years to 64 Years
Countries
United States, Canada, Poland, ...
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT04693351

Troriluzole for OCD

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.

In Canada
OCDOtherFrom 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.